Suchergebnisse - "Carroll, Miles W"

PubPharm (238)

61

One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model

enthalten in: Vaccine | 2021

von Gooch, K. | Smith, T. | Salguero, F. | +22

62

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

enthalten in: Cell | 2021

von Liu, C. | Ginn, H. | Dejnirattisai, W. | +56

63

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models

enthalten in: Communications biology | 2021

von Lambe, T. | Spencer, A. | Thomas, K. | +41

64

Diagnosis of SARS-CoV-2 infection with LamPORE, a high-throughput platform combining loop-mediated isothermal amplification and nanopore sequencing

enthalten in: bioRxiv.org | 2021

von Peto, L. | Rodger, G. | Carter, D. | +19

65

Author Correction : Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

enthalten in: Nature medicine | 2021

von Barrett, J. | Belij-Rammerstorfer, S. | Dold, C. | +152

ErratumFor: Nat Med. 2021 Feb;27(2):279-288. - PMID 33335322

66

Antibody evasion by the P.1 strain of SARS-CoV-2

enthalten in: Cell | 2021

von Dejnirattisai, W. | Zhou, D. | Supasa, P. | +47

67

Diagnosis of SARS-CoV-2 Infection with LamPORE, a High-Throughput Platform Combining Loop-Mediated Isothermal Amplification and Nanopore Sequencing

enthalten in: Journal of clinical microbiology | 2021

von Peto, L. | Rodger, G. | Carter, D. | +19

68

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

enthalten in: Cell | 2021

von Zhou, D. | Dejnirattisai, W. | Supasa, P. | +41

69

Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts : an observational cohort study

enthalten in: The Lancet. Infectious diseases | 2021

von Thom, R. | Tipton, T. | Strecker, T. | +41

CommentIn: Lancet Infect Dis. 2021 Apr;21(4):441-442. - PMID 33065040

70

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

enthalten in: Cell | 2021

von Supasa, P. | Zhou, D. | Dejnirattisai, W. | +50

CommentIn: Signal Transduct Target Ther. 2021 Apr 10;6(1):151. - PMID 33839737